8-K filed January 7, 2026, 6:59 PM ET ticker APYP CIK 0001568969

M&A confidence high sentiment neutral materiality 0.80

AppYea acquires Techlott blockchain lottery technology; issues 1.28B shares (35% fully diluted)

APPYEA, INC

Consideration: 1,277,922,611 shares of common stock (35% fully diluted) for Techlott's blockchain lottery tech.
Issued 49,117 Series B Preferred shares (convert into 25,000 common each upon authorized share increase) pending shareholder vote.
$0.8M convertible notes converted into 245,013,836 common shares; $863,840 notes extended to Feb 2028 at 8% interest.
Appointed Mark Katzenelson (President) and Ben Harris (CTO) to board and officer roles; each gets $30k/month consulting fee for 3 years, with 36-month severance.

item 1.01 item 2.01 item 3.02 item 5.02 item 5.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-000819
form_type: 8-K
ticker: APYP
cik: 0001568969
company_name: APPYEA, INC
filed_at: 2026-01-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.481499+00:00
generated_at: 2026-05-16T11:21:41.742275+00:00
sec_items: ["1.01", "2.01", "3.02", "5.02", "5.03", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-000819
json_url: https://secwatch.observer/filing/0001493152-26-000819.json
markdown_url: https://secwatch.observer/filing/0001493152-26-000819.md
text_url: https://secwatch.observer/filing/0001493152-26-000819.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1568969/000149315226000819/0001493152-26-000819-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1568969/000149315226000819/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

5641ea65e421bb8f8cb4e1f7f32fe9c43f46779c

APPYEA, INC: Filed certificate of designation for Series B Preferred Stock on November 26, 2025, then amended conversion ratio on December 31, 2025 (effective 2025-11-26).

On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

a827474a4630af6c4e8b8092efac327bf532aa7b

APPYEA, INC completed an acquisition involving Techlott Ltd. for 1,277,922,611 shares of the Company’s common stock (closed 2025-12-31).

August 21, 2025 disclosing the entry into the IP Purchase Agreement. Pursuant to the terms of the IP Purchase Agreement, the aggregate consideration to be paid by the Company is 1,277,922,611 shares (the “Consideration Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), representing 35% of the Company’s issued and outstanding capital

SEC 8-K Item 2.01/5.01 confidence 0.9 SEC evidence

Comparable filings

APAD

Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M

Enhanced Group Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01

same fact type: governance_change, ma_transaction same SEC item: 1.01, 2.01, 3.02, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock.

Comparable filing

As a result of the Business Combination, the Company ceased being a shell company

Filing page SEC filing

CHRN

Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.

EKSO BIONICS HOLDINGS, INC. May 5, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 9.01

same fact type: governance_change, ma_transaction same SEC item: 1.01, 2.01, 3.02, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock.

Comparable filing

on May 1, 2026, the Company filed the Second Amended and Restated Articles of Incorporation (the “A&R Articles”) with the Secretary of State of the State of Nevada with a delayed effective date and time of 3:00 a.m. (Eastern Time) on May 5, 2026.

Filing page SEC filing

GYRE

Gyre Therapeutics completes $300M all-stock acquisition of Cullgen; appoints Ying Luo as CEO

GYRE THERAPEUTICS, INC. May 4, 2026, 7:59 PM ET m_and_a Items 2.01, 5.03, 1.01, 3.02, 3.03, 5.02, 7.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 1.01, 2.01, 3.02, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock.

Comparable filing

The Company has filed with the Secretary of State of the State of Delaware a Certificate of Designation of Preferences, Rights and Limitations of the Company Preferred Stock (the “Certificate of Designation”) in connection with the Merger referenced in Item 1.01 above.

Filing page SEC filing

OCFC

OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus

OCEANFIRST FINANCIAL CORP June 1, 2026, 5:19 PM ET m_and_a Items 1.01, 3.02, 2.01, 2.03, 3.03, 5.02, 5.03, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

August 21, 2025 disclosing the entry into the IP Purchase Agreement. Pursuant to the terms of the IP Purchase Agreement, the aggregate consideration to be paid by the Company is 1,277,922,611 shares (the “Consideration Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), representing 35% of the Company’s issued and outstanding capital

Comparable filing

of Flushing (“ Flushing Common Stock ”) issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, was converted into the right to receive 0.85 of a share (the “ Exchange Ratio ”) of common stock, par value $0.01 per share, of OceanFirst (“ OceanFirst Common Stock ” and such consideration, the “ Merger Consideration ”).

Filing page SEC filing

SHPH

Shuttle Pharma completes merger with United Dogecoin, pivots to crypto, raises $9.55M PIPE

Shuttle Pharmaceuticals Holdings, Inc. May 7, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

August 21, 2025 disclosing the entry into the IP Purchase Agreement. Pursuant to the terms of the IP Purchase Agreement, the aggregate consideration to be paid by the Company is 1,277,922,611 shares (the “Consideration Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), representing 35% of the Company’s issued and outstanding capital

Comparable filing

On May 6, 2026 (the “ Closing Date ”), Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), completed its previously announced merger pursuant to an Agreement and Plan of Merger (the “ Merger Agreement ”), entered into on April 30, 2026 by and among the Acquiror, Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).

Filing page SEC filing

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 1.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock.

Comparable filing

In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.

Filing page SEC filing

EWCZ

European Wax Center completes take-private by General Atlantic at $5.80/share; stock delisted

European Wax Center, Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.02, 5.03, 5.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

August 21, 2025 disclosing the entry into the IP Purchase Agreement. Pursuant to the terms of the IP Purchase Agreement, the aggregate consideration to be paid by the Company is 1,277,922,611 shares (the “Consideration Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), representing 35% of the Company’s issued and outstanding capital

Comparable filing

excluded shares pursuant to the terms of the Merger Agreement, was cancelled and extinguished and automatically converted into the right to receive an amount in cash equal to $5.80 per share of Class A Common Stock, without interest thereon (the “ Class A Per Share Price ”), (ii) each share of the Company’s Class B common stock, par value $0.00001 per share

Filing page SEC filing

DVN

Devon completes all-stock merger with Coterra; combined company retains DVN ticker

DEVON ENERGY CORP/DE May 7, 2026, 7:59 PM ET m_and_a Items 2.01, 5.02, 5.03, 7.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 2.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

On November 26, 2025, the Company filed a certificate of designation (the “B Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B Preferred Stock.

Comparable filing

On May 7, 2026, the Company filed an amendment to the Company’s restated certificate of incorporation (the “ Authorized Share Charter Amendment ”), effective as of such date, increasing the number of authorized shares of Company Common Stock from 1,000,000,000 to 2,000,000,000.

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-000819

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.